Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography
- PMID: 34605437
- PMCID: PMC8488854
- DOI: 10.1107/S2053230X21009195
Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography
Abstract
The Ca2+-dependent enzyme peptidyl-arginine deiminase type III (PAD3) catalyses the deimination of arginine residues to form citrulline residues in proteins such as keratin, filaggrin and trichohyalin. This is an important post-translation modification that is required for normal hair and skin formation in follicles and keratocytes. The structure of apo human PAD3 was determined by X-ray crystallography to a resolution of 2.8 Å. The structure of PAD3 revealed a similar overall architecture to other PAD isoforms: the N-terminal and middle domains of PAD3 show sequence and structural variety, whereas the sequence and structure of the C-terminal catalytic domain is highly conserved. Structural analysis indicates that PAD3 is a dimer in solution, as is also the case for the PAD2 and PAD4 isoforms but not the PAD1 isoform.
Keywords: calcium binding; hair follicles; peptidyl-arginine deiminase; post-translational modifications; protein citrullination.
Figures



Similar articles
-
Deimination in epidermal barrier and hair formation.Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220245. doi: 10.1098/rstb.2022.0245. Epub 2023 Oct 2. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37778378 Free PMC article. Review.
-
Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.Arch Biochem Biophys. 2021 Sep 15;708:108911. doi: 10.1016/j.abb.2021.108911. Epub 2021 May 7. Arch Biochem Biophys. 2021. PMID: 33971157
-
Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.J Mol Biol. 2016 Jul 31;428(15):3058-73. doi: 10.1016/j.jmb.2016.06.018. Epub 2016 Jul 5. J Mol Biol. 2016. PMID: 27393304
-
Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin.J Invest Dermatol. 2000 Nov;115(5):813-23. doi: 10.1046/j.1523-1747.2000.00131.x. J Invest Dermatol. 2000. PMID: 11069618
-
Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?Inflammopharmacology. 2023 Apr;31(2):731-744. doi: 10.1007/s10787-023-01149-5. Epub 2023 Feb 17. Inflammopharmacology. 2023. PMID: 36806957 Review.
Cited by
-
Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.IUCrJ. 2024 May 1;11(Pt 3):395-404. doi: 10.1107/S2052252524002549. IUCrJ. 2024. PMID: 38656308 Free PMC article.
-
Deimination in epidermal barrier and hair formation.Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220245. doi: 10.1098/rstb.2022.0245. Epub 2023 Oct 2. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37778378 Free PMC article. Review.
-
Co-expression of PADI isoforms during progenitor differentiation enables functional diversity.Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220451. doi: 10.1098/rstb.2022.0451. Epub 2023 Oct 2. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37778375 Free PMC article.
-
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection.Int J Mol Sci. 2024 Aug 9;25(16):8709. doi: 10.3390/ijms25168709. Int J Mol Sci. 2024. PMID: 39201398 Free PMC article.
References
-
- Arita, K., Hashimoto, H., Shimizu, T., Nakashima, K., Yamada, M. & Sato, M. (2004). Nat. Struct. Mol. Biol. 11, 777–783. - PubMed
-
- Assohou-Luty, C., Raijmakers, R., Benckhuijsen, W. E., Stammen-Vogelzangs, J., de Ru, A., van Veelen, P. A., Franken, K. L., Drijfhout, J. W. & Pruijn, G. J. (2014). Biochim. Biophys. Acta, 1844, 829–836. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous